Compassion Meditation for PTSD

Not Applicable

Completed

• Conditions: Posttraumatic Stress Disorder
• Interventions: Behavioral: Relaxation; Behavioral: Compassion Meditation (CM)

• Registration Number: NCT02372396
• Lead Sponsor: Veterans Medical Research Foundation

Brief Summary

The goal of this project is to refine an existing compassion meditation protocol for individuals with posttraumatic stress disorder (PTSD), to examine the safety and feasibility of this approach and to collect data to make initial estimates of efficacy.

Detailed Description

There is considerable public and professional interest in complementary and alternative approaches, including meditation, for managing posttraumatic stress disorder (PTSD), but there is little empirical support to guide their use. Multiple meditative techniques can be applied to the amelioration of this disorder, and the literature suggests that they operate by different mechanisms. Compassion meditation is a meditative practice focused on the wish that others and the self may be free of suffering. Because this particular form of meditation has been shown to elicit positive emotion and feelings of connection with other people, it is uniquely well suited to addressing PTSD, which is characterized by strong negative affect, deficits in positive emotion and social connectedness.

Compassion meditation has not been evaluated for use with PTSD patients; therefore, the goal of this project is to refine an existing compassion meditation protocol for individuals with PTSD, to examine the safety and feasibility of this approach and to collect data to make initial estimates of efficacy. The proposed project will be completed in two phases.

In phase one, the compassion meditation protocol will be executed with individuals with PTSD and iteratively refined based on therapist and participant feedback. In addition, a relaxation protocol that was used in a previous PTSD trial will be modified to match the length and format of the meditative practice.

In phase two, the investigators will complete a pilot study to examine the feasibility of conducting a randomized trial comparing these interventions and to provide information that will allow us to better design future projects. Ultimately, the research informed by this project may provide an additional option for treatment of PTSD, which would be an important contribution because existing treatment approaches are not universally acceptable or effective.

Study Timeline

• Study Start: 2015-02
• Study First Submitted: 2015-02-03
• Study First Submitted QC: 2015-02-20
• Study First Posted: 2015-02-26
• Primary Completion: 2017-12
• Study Completion: 2018-06
• Results First Submitted: 2018-06-05
• Status Verified: 2018-08
• Results First Submitted QC: 2018-08-05
• Last Update Submitted: 2018-08-05
• Results First Posted: 2018-09-05
• Last Update Posted: 2018-09-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

• Veteran of at least 18 years of age
• PTSD as defined by the Diagnostic and Statistical Manual Version 5 (DSM-5)
• Capacity to consent
• Willing to commit to 8 consecutive weekly sessions lasting 2 hours in duration and to complete assessment materials.

Exclusion Criteria

• Serious suicidality or homicidality that has required urgent or emergent evaluation or treatment within the past three months
• A known, untreated substance use disorder (inclusion is possible if there is evidence that the individual has been afforded and is complying with treatment for the substance problem)
• Serious Axis I mental disorders, such as psychotic disorders or bipolar type I, or serious dissociative symptoms
• Cognitive impairment that would interfere with consent or treatment
• Circumstances that lead to recurrent traumatization (e.g., engaged in a violent relationship)
• Concurrent enrollment in any other treatment specifically targeting PTSD symptoms or social functioning (e.g., couples therapy)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Relaxation	Relaxation	Relaxation delivered in 10 2-hour group treatment sessions.
Compassion Meditation	Compassion Meditation (CM)	Compassion Meditation delivered in 10 2-hour group treatment sessions.

Primary Outcome Measures

Name	Time	Method
Clinician Administered PTSD Scale -5 (CAPS-5) PTSD Severity	Baseline and 10 weeks	Clinical interview that quantifies PTSD symptomatology according to DSM-5, generating a continuous measure of severity (range 0-80) where higher scores indicate more symptomatology

Trial Locations

Locations (1)

VA San Diego Healthcare System; 🇺🇸 San Diego, California, United States